Bristol-Myers Squibb
BMY
$44.03
Share price
-0.18%
Change (1 day)
-33.82%
Change (1 year)
Categories
Earnings for Bristol-Myers Squibb (BMY)
Earnings in 2023 (TTM): $8.44 B
According to Bristol-Myers Squibb's latest financial reports the company's current earnings (TTM) are -$5.85 B. In 2022 the company made an earning of $7.71 B a decrease over its 2021 earnings that were of $8.09 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bristol-Myers Squibb from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $8.44 B | 9.43% |
| 2022 | $7.71 B | -4.75% |
| 2021 | $8.09 B | -217.86% |
| 2020 | -$6.88 B | -238.11% |
| 2019 | $4.97 B | -16.64% |
| 2018 | $5.96 B | 16.31% |
| 2017 | $5.13 B | -13.25% |
| 2016 | $5.91 B | 184.79% |
| 2015 | $2.07 B | -12.77% |
| 2014 | $2.38 B | -17.64% |
| 2013 | $2.89 B | 23.55% |
| 2012 | $2.34 B | -66.48% |
| 2011 | $6.98 B | 14.99% |
| 2010 | $6.07 B | 20.58% |
| 2009 | $5.03 B | -7.97% |
| 2008 | $5.47 B | 74.12% |
| 2007 | $3.14 B | 19.24% |
| 2006 | $2.63 B | -41.65% |
| 2005 | $4.51 B | 2.59% |
| 2004 | $4.40 B | -10.76% |
| 2003 | $4.93 B | 86.36% |
| 2002 | $2.64 B | -6.27% |
| 2001 | $2.82 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -465.43% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -268.10% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | -155.88% | 🇺🇸 USA |
 AbbVie ABBV | $6.25 B | -206.91% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | -229.34% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | -234.37% | 🇺🇸 USA |
 Sanofi SNY | $7.26 B | -224.20% | 🇫🇷 France |
 Biogen BIIB | $1.32 B | -122.64% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -151.92% | 🇺🇸 USA |
 AstraZeneca AZN | $9.08 B | -255.34% | 🇬🇧 UK |